Pharming Group NVPharming Group NVPharming Group NV

Pharming Group NV

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
0.00USD
Revenue estimate
‪68.43 M‬USD
Market capitalization
‪646.21 M‬USD
−0.0159USD
‪−10.77 M‬USD
‪250.45 M‬USD
‪659.49 M‬
Beta (1Y)
0.77

About PHARMING GROUP

CEO
Sijmen de Vries
Headquarters
Leiden
Founded
1988
ISIN
NL0010391025
FIGI
BBG000G4B509
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PHGUF is 0.9539 USD — it has increased by 5.38% in the past 24 hours. Watch Pharming Group NV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Pharming Group NV stocks are traded under the ticker PHGUF.
Pharming Group NV is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
PHGUF stock is 5.10% volatile and has beta coefficient of 0.77. Track Pharming Group NV stock price on the chart and check out the list of the most volatile stocks — is Pharming Group NV there?
PHGUF earnings for the last quarter are 0.00 USD per share, whereas the estimation was −0.01 USD resulting in a 103.85% surprise. The estimated earnings for the next quarter are 0.00 USD per share. See more details about Pharming Group NV earnings.
Pharming Group NV revenue for the last quarter amounts to ‪66.70 M‬ USD despite the estimated figure of ‪61.67 M‬ USD. In the next quarter revenue is expected to reach ‪71.83 M‬ USD.
Yes, you can track Pharming Group NV financials in yearly and quarterly reports right on TradingView.
PHGUF stock has risen by 0.41% compared to the previous week, the month change is a 19.16% fall, over the last year Pharming Group NV has showed a 12.49% decrease.
PHGUF net income for the last quarter is ‪−2.77 M‬ USD, while the quarter before that showed ‪3.37 M‬ USD of net income which accounts for −182.32% change. Track more Pharming Group NV financial stats to get the full picture.
Today Pharming Group NV has the market capitalization of ‪646.56 M‬, it has increased by 4.75% over the last week.
No, PHGUF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PHGUF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharming Group NV stock right from TradingView charts — choose your broker and connect to your account.
PHGUF reached its all-time high on Oct 13, 2000 with the price of 11.5000 USD, and its all-time low was 0.0100 USD and was reached on Oct 1, 2012. View more price dynamics on PHGUF chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharming Group NV technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharming Group NV stock shows the strong sell signal. See more of Pharming Group NV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Pharming Group NV future price: according to them, PHGUF price has a max estimate of 4.00 USD and a min estimate of 1.63 USD. Watch PHGUF chart and read a more detailed Pharming Group NV stock forecast: see what analysts think of Pharming Group NV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pharming Group NV EBITDA is ‪−12.99 M‬ USD, and current EBITDA margin is −4.49%. See more stats in Pharming Group NV financial statements.